17-83085251-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000320095.12(METRNL):c.484G>A(p.Gly162Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 1,573,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000320095.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METRNL | NM_001004431.3 | c.484G>A | p.Gly162Ser | missense_variant | 2/4 | ENST00000320095.12 | NP_001004431.1 | |
METRNL | NM_001363853.2 | c.238G>A | p.Gly80Ser | missense_variant | 3/5 | NP_001350782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METRNL | ENST00000320095.12 | c.484G>A | p.Gly162Ser | missense_variant | 2/4 | 1 | NM_001004431.3 | ENSP00000315731.6 | ||
METRNL | ENST00000571814.1 | c.238G>A | p.Gly80Ser | missense_variant | 1/3 | 1 | ENSP00000460798.1 | |||
METRNL | ENST00000570778.5 | c.238G>A | p.Gly80Ser | missense_variant | 2/4 | 5 | ENSP00000458566.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 7AN: 219630Hom.: 0 AF XY: 0.0000255 AC XY: 3AN XY: 117602
GnomAD4 exome AF: 0.0000204 AC: 29AN: 1421650Hom.: 0 Cov.: 36 AF XY: 0.0000242 AC XY: 17AN XY: 702390
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74370
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at